Table 4 Delayed bleeding risk according to the two different sensitivity analyses performed
Study | MTBI | Sensitivity |
|---|---|---|
ANTONI_2019 | NA | 1.85% (0.23–6.53%) |
BATTLE_2017 | NA | 2.27% (0.06–12.02%) |
CHENOWETH_2018 | NA | 7.11% (3.94–11.64%) |
ERNSTBRUNNER_2016 | 1.05% (0.29–2.66%) | 1.05% (0.29–2.66%) |
GALLIAZZO_2019 | 1.53% (0.19–5.41%) | 1.53% (0.19–5.41%) |
GANETSKY_2017 | NA | 3.61% (2.30–5.37%) |
HILL_2018 | NA | 3.29% (1.33–6.65%) |
HUANG_2019 | NA | 2.52% (0.52–7.19%) |
MANN_2018 | NA | 0.00% (0.00–3.18%) |
NISHIJIMA_2012 | 0.00% (0.00–1.53%) | 1.23% (0.26–3.57%) |
PECK_2011 | NA | 0.00% (0.00–3.52%) |
SCANTLING_2017 | 1.21% (0.15–4.31%) | 1.2% (0.15–4.28%) |
STANITSAS_2016 | NA | 0.00% (0.00–8.81%) |
SWAP_2016 | NA | 2.31% (0.85–4.95%) |
TAUBER_2009 | 4.00% (1.10–9.93%) | 4.00% (1.10–9.93%) |
TAYLOR_2012 | NA | 0.00% (0.00–4.25%) |
No. studies | 5 | 16 |
DB mean estimated risk | 1.04% (0.15–2.49%) | 1.70% (0.93–2.67%) |
p value for heterogeneity | p = 0.0334 | p = 0.0012 |
I2 statistic | 62% | 60% |